Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study

Philly O'Riordan, Uli Schwab, Sarah Logan et al. · 2008

Read Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study by Philly O'Riordan, Uli Schwab, Sarah Logan et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003173.txt.

Description

Philly O'Riordan, Uli Schwab, Sarah Logan and colleagues report on fast drug resistance testing for tuberculosis in this 2008 PLOS ONE paper. Multi-drug resistant tuberculosis is a major public health concern because diagnosis is often delayed, raising spread to the community and health workers. Treatment is prolonged, and the total cost of a single case is high. Diagnosis had traditionally been slow.

Their case-control study tests whether rapid molecular detection of rifampicin resistance speeds early diagnosis and treatment of resistant disease. Readers get a practical check on a faster test where time matters. Quicker results can mean earlier correct therapy and less transmission.

Catalog record

CREATORPhilly O'Riordan, Uli Schwab, Sarah Logan et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003173

Browse the full library · About the Tower of Babel